ATC Group: N04BA Dopa and dopa derivatives

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N04BA in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N04 Anti-parkinson drugs
3 N04B Dopaminergic agents
4 N04BA Dopa and dopa derivatives

Group N04BA contents

Code Title
N04BA01 Levodopa
N04BA02 Levodopa and decarboxylase inhibitor
N04BA03 Levodopa, decarboxylase inhibitor and COMT inhibitor
N04BA04 Melevodopa
N04BA05 Melevodopa and decarboxylase inhibitor
N04BA06 Etilevodopa and decarboxylase inhibitor
N04BA07

Active ingredients in N04BA

Active Ingredient

Levodopa is a precursor of dopamine, and is given as dopamine replacement therapy in Parkinson's disease.

Levodopa is a precursor of dopamine, and is given as replacement therapy in Parkinson's disease. Carbidopa is a peripheral dopa decarboxylase inhibitor. It prevents metabolism of levodopa to dopamine in the peripheral circulation, ensuring that a higher proportion of the dose reaches the brain, where dopamine acts. A lower dose of levodopa can be used, reducing the incidence and severity of side-effects.

Related product monographs

Document Type Information Source  
 CORBILTA Film-coated tablet MPI, EU: SmPC European Medicines Agency (EU)
 CREDANIL Tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 DUODOPA Intestinal gel MPI, EU: SmPC Health Products Regulatory Authority (IE)
 INBRIJA Inhalation powder, capsule MPI, US: SPL/PLR FDA, National Drug Code (US)
 INBRIJA Inhalation powder, hard capsule MPI, EU: SmPC European Medicines Agency (EU)
 LEVOMED Tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 MADOPAR Capsule, Rapid dispersible tablet MPI, EU: SmPC Medicines and Medical Devices Safety Authority (NZ)
 PRODUODOPA Solution for infusion MPI, EU: SmPC Health Products Regulatory Authority (IE)
 STALEVO Film-coated tablet MPI, EU: SmPC European Medicines Agency (EU)
⇈